NCT00335335View on ClinicalTrials.gov

Safety and Effectiveness of Visipaque 320mg-I/ml for Use in Contrast-Enhanced CT Angiography of Arteries of the Heart

PHASE3TerminatedINTERVENTIONAL
Enrollment

89

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

December 2, 2006

Study Completion Date

December 2, 2006

Conditions
Coronary Artery Disease
Interventions
DRUG

iodixanol

Trial Locations (1)

08540

Princeton

Sponsors

Lead Sponsor

GE Healthcare
All Listed Sponsors
lead

GE Healthcare

INDUSTRY